Mary Ann Liebert, Inc.

The use of telemedicine to help manage chronic diseases can yield clear benefits including fewer and shorter hospital stays, fewer emergency room visits, less severe illness, and even fewer deaths, as reported in Telemedicine and e-Health.

A detailed discussion of the metabolic disorders and functional abnormalities that can develop, and nutritional treatments for these is presented in a Review article published in Journal of Medicinal Food.

Auriculotherapy, a form of acupuncture that involves stimulating targeted points on the outer ear, may help in managing constipation. Evidence from clinical studies is presented in The Journal of Alternative and Complementary Medicine.

How live discharge rates differ between hospice programs and geographic regions, and when those rates should raise red flags are among the issues explored in the article "A National Study of Live Discharges from Hospice."

An insightful Roundtable Discussion focused on how to apply these novel toxicology models to everyday hazard prediction, risk assessment, and decision making in industry is published in the preview issue of the new journal Applied In Vitro Toxicology

We have pills to ease pain, to cure infection, to help us lose weight, to treat chronic conditions, and to enhance our sexual and athletic prowess. Why do pills play such a central role in today's society and could we benefit from taking fewer pills?

Zebrafish, a model organism that plays an important role in biological research and the discovery and development of new drugs and cell-based therapies, can form embryonic stem cells (ESCs).

St. John's wort is the most frequently used complementary and alternative medicine (CAM) treatment in the U.S. for depression and similar psychiatric disorders.

A new study that identifies MSG as a critical factor in the initiation of obesity and shows that a restrictive diet cannot counteract this effect but can slow the progression of related liver disease is published in Journal of Medicinal Food.

The powerful anti-inflammatory compound interleukin-10 (IL-10) plays a crucial role in regenerative, scarless healing of fetal skin. Studies of IL-10 in postnatal skin wounds have demonstrated its promise as an anti-scarring therapeutic agent.